Katelyn W Sylvester
Overview
Explore the profile of Katelyn W Sylvester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
May J, Allen A, Samuelson Bannow B, OConnor C, Sylvester K, Kaatz S
J Thromb Haemost
. 2024 Dec;
23(3):779-789.
PMID: 39667688
Anticoagulant use is prevalent and associated with significant potential for harm. Anticoagulation stewardship practice has emerged to address care gaps and promote safe, effective, and cost-conscious anticoagulation use across health...
2.
Zuin M, Bikdeli B, Ballard-Hernandez J, Barco S, Battinelli E, Giannakoulas G, et al.
J Am Coll Cardiol
. 2024 Oct;
84(16):1561-1577.
PMID: 39384264
Despite abundant clinical innovation and burgeoning scientific investigation, pulmonary embolism (PE) has continued to pose a diagnostic and management challenge worldwide. Aging populations, patients living with a mounting number of...
3.
Zon R, Sylvester K, Rubins D, Grandoni J, Kelly J, Timilsina S, et al.
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102423.
PMID: 38953054
Background: Heparin-induced thrombocytopenia (HIT) is a difficult clinicopathologic diagnosis to make and to treat. Delays in identification and appropriate treatment can lead to increased morbidity and mortality. Objectives: To use...
4.
Sylvester K, Grandoni J, Rhoten M, Coakley L, Lyons-Matiello E, Frankel K, et al.
J Card Fail
. 2024 Mar;
30(9):1111-1119.
PMID: 38521486
Background: Patients with left ventricular assist devices (LVADs) require interruption of warfarin for invasive procedures, but parenteral bridging is associated with many complications. Four-factor prothrombin complex concentrate (4F-PCC) can temporarily...
5.
Schurr J, Ambrosi L, Fitzgerald J, Bermudez C, Genuardi M, Brahier M, et al.
Artif Organs
. 2024 Mar;
48(8):921-931.
PMID: 38459758
Background: The efficacy of extracorporeal membrane oxygenation (ECMO) as a bridge to left ventricular assist device (LVAD) remains unclear, and recipients of the more contemporary HeartMate 3 (HM3) LVAD are...
6.
Corcoran D, Kovacevic M, Dellorfano H, Sylvester K, Connors J
Crit Pathw Cardiol
. 2024 Jan;
23(3):159-165.
PMID: 38285539
Introduction: Brigham and Women's Hospital historically used titratable weight-based heparin nomograms with as needed boluses managed by extracorporeal membrane oxygenation specialists to achieve a predetermined goal-activated partial thromboplastin time (aPTT)....
7.
Lucas F, Lewis J, Grandoni J, Sylvester K, Bernier T, Ting C, et al.
Am J Clin Pathol
. 2023 Aug;
160(6):571-584.
PMID: 37549067
Objectives: Quantification of direct oral anticoagulant (DOAC) plasma levels can guide clinical management, but insight into clinical scenarios surrounding DOAC-calibrated anti-FXa assays is limited. Methods: Apixaban- and rivaroxaban-calibrated chromogenic anti-Xa...
8.
Albuloushi A, Rhoten M, Kelly J, Sylvester K, Grandoni J, Connors J
J Thromb Thrombolysis
. 2022 Sep;
54(4):597-604.
PMID: 36129561
Historically, treatment of heparin-induced thrombocytopenia (HIT) includes a non-heparin parenteral anticoagulant with bridging to warfarin once platelets recover. Data supporting the use of direct oral anticoagulants (DOACs) for HIT treatment...
9.
Sylvester K, Chen A, Lewin A, Fanikos J, Goldhaber S, Connors J
Res Pract Thromb Haemost
. 2022 May;
6(3):e12696.
PMID: 35541695
Background: In 2017, the Brigham and Women's Hospital Anticoagulation Management Service (BWH AMS) expanded services to patients on direct oral anticoagulants (DOACs). We have since updated our DOAC management plan...
10.
Bikdeli B, Khairani C, Barns B, Rosovsky R, Jimenez D, Monreal M, et al.
Contemp Clin Trials
. 2022 Feb;
115:106714.
PMID: 35202841
No abstract available.